Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd. represents the apex of supplement manufacturing, bridging the gap between rigorous Chinese Academy of Sciences (CAS) research and global commercial scalability. Since 2012, we have redefined the "Made in China" narrative, shifting from volume-based production to high-value, science-driven contract manufacturing. As an established ODM/OEM partner, we operate from Shanghai, serving global brands that demand safety, efficacy, and innovation in their private label portfolios.
In an era of global volatility, SINOFN provides a robust supply chain fortress. Our manufacturing infrastructure is designed for agility and compliance:
At SINOFN, innovation is a strategic asset. Our R&D mandate, spearheaded by our Tianjin R&D center in collaboration with the Chinese Academy of Sciences, focuses on three pillars:
Medical Innovation Director. Ph.D from Peking University Medical School with 15+ years of experience in metabolic disorder formulations.
R&D Lead. Associate Researcher at CAS Postdoc, specializing in bioactive compound delivery systems.
Formulation Director. Senior Scientist from the Netherlands, focusing on EU regulatory standards and delivery tech.
We offer scalable solutions. While we support large enterprise orders, our pilot-scale prototyping capability allows startups to test the market with smaller, agile batch sizes before full-scale commercialization.
Our regulatory team maintains a live database of international supplement ingredient status. We conduct rigorous label verification and ingredient compliance reviews during the R&D phase to ensure your product meets FDA, EU, or local regional standards.
We specialize in both custom innovation and contract manufacturing. Our R&D team can perform reverse-engineering analysis to improve bioavailability or manufacturing efficiency of existing formulas, always adhering to strict IP protection protocols.
